Global Drug Facility
Tuberculosis bedaquiline
World
Johnson & Johnson’s TB drug deal will fail to reach all those in need

A recent deal struck between Johnson & Johnson and the Global Drug Facility promises improved access to bedaquiline in a number of low income countries, but fails to address structural problems


    All text content published on peoplesdispatch.org is the property of Peoples Dispatch and is under a Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA) license.
    For license to republish any audio, video or image content, please get in touch with the Peoples Dispatch Team.
    Share on Facebook Share
    Share on Twitter Tweet
    Share on Reddit Share
    Share on Whatsapp Share
    Send email Mail
    Print this Print